BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31310811)

  • 21. Growth differentiation factor-15 in the early diagnosis and risk stratification of patients with acute chest pain.
    Schaub N; Reichlin T; Twerenbold R; Reiter M; Steuer S; Bassetti S; Stelzig C; Wolf C; Winkler K; Haaf P; Meissner J; Drexler B; Mueller C
    Clin Chem; 2012 Feb; 58(2):441-9. PubMed ID: 22205695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.
    Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
    PLoS One; 2018; 13(3):e0194152. PubMed ID: 29529072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GDF-15 (Growth Differentiation Factor 15) Is Associated With Lack of Ventricular Recovery and Mortality After Transcatheter Aortic Valve Replacement.
    Kim JB; Kobayashi Y; Moneghetti KJ; Brenner DA; O'Malley R; Schnittger I; Wu JC; Murtagh G; Beshiri A; Fischbein M; Miller DC; Liang D; Yeung AC; Haddad F; Fearon WF
    Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29222133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.
    Rohatgi A; Patel P; Das SR; Ayers CR; Khera A; Martinez-Rumayor A; Berry JD; McGuire DK; de Lemos JA
    Clin Chem; 2012 Jan; 58(1):172-82. PubMed ID: 22065155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
    Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
    Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.
    Lankeit M; Kempf T; Dellas C; Cuny M; Tapken H; Peter T; Olschewski M; Konstantinides S; Wollert KC
    Am J Respir Crit Care Med; 2008 May; 177(9):1018-25. PubMed ID: 18263797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-based cardiogenic shock patient classifier.
    Rueda F; Borràs E; García-García C; Iborra-Egea O; Revuelta-López E; Harjola VP; Cediel G; Lassus J; Tarvasmäki T; Mebazaa A; Sabidó E; Bayés-Genís A
    Eur Heart J; 2019 Aug; 40(32):2684-2694. PubMed ID: 31204432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain.
    Eggers KM; Kempf T; Allhoff T; Lindahl B; Wallentin L; Wollert KC
    Eur Heart J; 2008 Oct; 29(19):2327-35. PubMed ID: 18664460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer.
    Engerud H; Hope K; Berg HF; Fasmer KE; Tangen IL; Haldorsen IS; Trovik J; Krakstad C
    PLoS One; 2019; 14(1):e0210585. PubMed ID: 30645608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
    Hagström E; Held C; Stewart RA; Aylward PE; Budaj A; Cannon CP; Koenig W; Krug-Gourley S; Mohler ER; Steg PG; Tarka E; Östlund O; White HD; Siegbahn A; Wallentin L;
    Clin Chem; 2017 Jan; 63(1):325-333. PubMed ID: 27811204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between Plasma Levels of Growth Differentiation Factor-15 and Renal Function in the Elderly: Korean Frailty and Aging Cohort Study.
    Kim JS; Kim S; Won CW; Jeong KH
    Kidney Blood Press Res; 2019; 44(3):405-414. PubMed ID: 31163432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of growth differentiation factor 15 with other key biomarkers, functional parameters and mortality in community-dwelling older adults.
    Rothenbacher D; Dallmeier D; Christow H; Koenig W; Denkinger M; Klenk J;
    Age Ageing; 2019 Jul; 48(4):541-546. PubMed ID: 30855645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between serum growth differentiation factor-15 and 3-month depression after acute ischemic stroke.
    Lu X; Duan J; Cheng Q; Lu J
    J Affect Disord; 2020 Jan; 260():695-702. PubMed ID: 31561112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact.
    Doerstling S; Hedberg P; Öhrvik J; Leppert J; Henriksen E
    Ups J Med Sci; 2018 Jun; 123(2):86-93. PubMed ID: 29714603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; Denks D; de Waha S; Pöss J; Heine GH; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Int J Cardiol; 2015 Jul; 191():159-66. PubMed ID: 25965624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth differentiation factor-15 and all-cause mortality in patients with suspected myocardial infarction.
    Walter J; Nestelberger T; Boeddinghaus J; Twerenbold R; Croton L; Badertscher P; Wildi K; Wussler D; du Fay de Lavallaz J; Mueller C;
    Int J Cardiol; 2019 Oct; 292():241-245. PubMed ID: 31174919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgery.
    Guenancia C; Kahli A; Laurent G; Hachet O; Malapert G; Grosjean S; Girard C; Vergely C; Bouchot O
    Int J Cardiol; 2015 Oct; 197():66-71. PubMed ID: 26113476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
    Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
    PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.